St. Augustine's double-digit adjusted operating income growth is set to contribute significantly to 2026 results, with expectations for further gains in 2027. Management noted, "There will not be a ...

I recently spoke with a college friend whose profession is teaching. He left the classroom—not because he stopped caring about it but because he wanted to take care of his special needs son. He ...

With FDA alignment on the potential to pool data across the full TSHA-102 development program and our BLA submission, we believe the longer term Part A data has the potential to strengthen the overall ...

We deployed $528 million of capital on attractive royalty deals in the quarter. At the same time, we returned approximately $186 million to our shareholders, including share repurchases of $50 million ...

LifeMD, Inc. ( LFMD) Q1 2026 Earnings Call May 6, 2026 4:30 PM EDT Good afternoon. Thank you for joining us today to discuss LifeMD's results for the first quarter ended March 31, 2026.

United Therapeutics Corporation (NASDAQ: UTHR) Q1 2026 Earnings Call Transcript May 6, 2026 United Therapeutics Corporation ...

Operator: Ladies and gentlemen, thank you for standing by. At this time, I would like to welcome everyone to the Tempus AI, Inc. First Quarter 2026 Financial Results Conference Call.

Cash Position -- $119.3 million in cash and cash equivalents as of March 31, 2025, compared to $34.9 million a year earlier; ...

Commercial Cell and Gene Therapy Revenue -- $9.1 million, up 26% year over year, reflecting growth in therapies supported.

Good morning, and thank you for joining us for the Neuronetics First Quarter 2026 Conference Call. Joining me on today's call is Neuronetics ...

Your movements,” the neuroscientist and psychologist Lisa Feldman Barrett told me, “whether it’s on your face or in your body ...